Publications by authors named "Andrea Kündgen"

48Publications

Neut-X can be successfully used as diagnostic and prognostic tool in MDS.

Leuk Res 2019 11 13;86:106224. Epub 2019 Sep 13.

Universitätsklinikum Düsseldorf, Heinrich-Heine-University, Moorenstr. 5, Düsseldorf, 40225, Germany.

View Article and Find Full Text PDF
November 2019

A retrospective study evaluating the impact of infectious complications during azacitidine treatment.

Ann Hematol 2017 Jul 4;96(7):1097-1104. Epub 2017 May 4.

Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany.

View Article and Find Full Text PDF
July 2017

Change of prognosis of patients with myelodysplastic syndromes during the last 30 years.

Leuk Res 2015 Jul 15;39(7):679-83. Epub 2015 Apr 15.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany.

View Article and Find Full Text PDF
July 2015

Combining DNA methyltransferase and histone deacetylase inhibition to treat acute myeloid leukemia/myelodysplastic syndrome: achievements and challenges.

Cancer 2015 Feb 21;121(4):498-501. Epub 2014 Oct 21.

Division of Hematology-Oncology, University of Freiburg Medical Center, Freiburg, Germany.

View Article and Find Full Text PDF
February 2015

The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q--new prognostic markers are needed.

Authors:
Andrea Kuendgen

Leuk Res 2014 Mar 26;38(3):287-8. Epub 2013 Dec 26.

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Hospital Duesseldorf, Germany. Electronic address:

View Article and Find Full Text PDF
March 2014

Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.

Eur J Haematol 2009 Nov 22;83(5):477-82. Epub 2009 Jun 22.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University of Duesseldorf, Moorenstrasse 5, D-40225 Duesseldorf, Germany.

View Article and Find Full Text PDF
November 2009

Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy.

Leuk Res 2009 Sep 9;33(9):1189-93. Epub 2009 May 9.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Düsseldorf, Germany.

View Article and Find Full Text PDF
September 2009

The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome.

Haematologica 2009 May 31;94(5):729-32. Epub 2009 Mar 31.

Department of Haematology, Oncology and Clinical Immunology Heinrich-Heine-University, Moorenstrasse 5, Düsseldorf, Germany.

View Article and Find Full Text PDF
May 2009

Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly.

Cancer Treat Rev 2009 Apr 31;35(2):97-120. Epub 2008 Oct 31.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr 5, Düsseldorf 40225, Germany.

View Article and Find Full Text PDF
April 2009

Current status of epigenetic treatment in myelodysplastic syndromes.

Ann Hematol 2008 Aug 5;87(8):601-11. Epub 2008 Apr 5.

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine University, Düsseldorf, Germany.

View Article and Find Full Text PDF
August 2008

Valproic acid for the treatment of myeloid malignancies.

Cancer 2007 Sep;110(5):943-54

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany.

View Article and Find Full Text PDF
September 2007

Chronic myelomonocytic leukemia in the light of the WHO proposals.

Haematologica 2007 Jul;92(7):974-7

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.

View Article and Find Full Text PDF
July 2007

Is lenalidomide a new standard treatment for myelodysplastic syndrome?

Authors:
Andrea Kuendgen

Nat Clin Pract Oncol 2007 Jul 15;4(7):396-7. Epub 2007 May 15.

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.

View Article and Find Full Text PDF
July 2007

Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.

Haematologica 2006 Dec;91(12):1596-604

Department of Hematology, Oncology and Clinical Immunology Heinrich-Heine-University Moorenstr. 5, 40225 Düsseldorf, Germany.

View Article and Find Full Text PDF
December 2006

Myelodysplastic syndromes in patients younger than age 50.

J Clin Oncol 2006 Dec 6;24(34):5358-65. Epub 2006 Nov 6.

Department of Hematology, Oncology, and Clinical Immunology, and Institute of Human Genetics, Heinrich-Heine-University, Duesseldorf, Germany.

View Article and Find Full Text PDF
December 2006

Differences in epidemiology of MDS between Western and Eastern countries: Ethnic differences or environmental influence?

Leuk Res 2007 Jan 19;31(1):103-4. Epub 2006 Apr 19.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr. 5, 40225 Düsseldorf, Germany.

View Article and Find Full Text PDF
January 2007

Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine.

Leuk Res 2007 Feb 18;31(2):257-9. Epub 2006 Apr 18.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Moorenstr. 5, 40225 Düsseldorf, Germany.

View Article and Find Full Text PDF
February 2007

Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes.

Blood 2005 Oct 21;106(8):2633-40. Epub 2005 Jun 21.

Division of Hematology, Department of Internal Medicine, Saitama Medical School, 38 Morohongo, Moroyama, Iruma-gun, Saitama, 350-0495, Japan.

View Article and Find Full Text PDF
October 2005

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid.

Blood 2004 Sep 20;104(5):1266-9. Epub 2004 May 20.

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Moorenstrasse 5, D-40225 Düsseldorf, Germany.

View Article and Find Full Text PDF
September 2004